Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model. / Sigvard, Anne K.; Bojesen, Kirsten Borup; Ambrosen, Karen S.; Nielsen, Mette Ødegaard; Gjedde, Albert; Tangmose, Karen; Kumakura, Yoshitaka; Edden, Richard; Fuglø, Dan; Jensen, Lars Thorbjørn; Rostrup, Egill; Ebdrup, Bjørn H.; Glenthøj, Birte Yding.

In: Biological Psychiatry Global Open Science, Vol. 3, No. 3, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sigvard, AK, Bojesen, KB, Ambrosen, KS, Nielsen, MØ, Gjedde, A, Tangmose, K, Kumakura, Y, Edden, R, Fuglø, D, Jensen, LT, Rostrup, E, Ebdrup, BH & Glenthøj, BY 2023, 'Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model', Biological Psychiatry Global Open Science, vol. 3, no. 3. https://doi.org/10.1016/j.bpsgos.2022.05.004

APA

Sigvard, A. K., Bojesen, K. B., Ambrosen, K. S., Nielsen, M. Ø., Gjedde, A., Tangmose, K., Kumakura, Y., Edden, R., Fuglø, D., Jensen, L. T., Rostrup, E., Ebdrup, B. H., & Glenthøj, B. Y. (2023). Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model. Biological Psychiatry Global Open Science, 3(3). https://doi.org/10.1016/j.bpsgos.2022.05.004

Vancouver

Sigvard AK, Bojesen KB, Ambrosen KS, Nielsen MØ, Gjedde A, Tangmose K et al. Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model. Biological Psychiatry Global Open Science. 2023;3(3). https://doi.org/10.1016/j.bpsgos.2022.05.004

Author

Sigvard, Anne K. ; Bojesen, Kirsten Borup ; Ambrosen, Karen S. ; Nielsen, Mette Ødegaard ; Gjedde, Albert ; Tangmose, Karen ; Kumakura, Yoshitaka ; Edden, Richard ; Fuglø, Dan ; Jensen, Lars Thorbjørn ; Rostrup, Egill ; Ebdrup, Bjørn H. ; Glenthøj, Birte Yding. / Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model. In: Biological Psychiatry Global Open Science. 2023 ; Vol. 3, No. 3.

Bibtex

@article{a66714fedb114afd9747ac80c81a7fa8,
title = "Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Na{\"i}ve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model",
abstract = "BackgroundDisturbances in presynaptic dopamine activity and levels of GABA (gamma-aminobutyric acid) and glutamate plus glutamine collectively may have a role in the pathophysiology of psychosis, although separately they are poor diagnostic markers. We tested whether these neurotransmitters in combination improve the distinction of antipsychotic-na{\"i}ve patients with first-episode psychosis from healthy control subjects.MethodsWe included 23 patients (mean age 22.3 years, 9 male) and 20 control subjects (mean age 22.4 years, 8 male). We determined dopamine metabolism in the nucleus accumbens and striatum from 18F-fluorodopa (18F-FDOPA) positron emission tomography. We measured GABA levels in the anterior cingulate cortex (ACC) and glutamate plus glutamine levels in the ACC and left thalamus with 3T proton magnetic resonance spectroscopy. We used binominal logistic regression for unimodal prediction when we modeled neurotransmitters individually and for multimodal prediction when we combined the 3 neurotransmitters. We selected the best combination based on Akaike information criterion.ResultsIndividual neurotransmitters failed to predict group. Three triple neurotransmitter combinations significantly predicted group after Benjamini-Hochberg correction. The best model (Akaike information criterion 48.5) carried 93.5% of the cumulative model weight. It reached a classification accuracy of 83.7% (p = .003) and included dopamine synthesis capacity (Ki4p) in the nucleus accumbens (p = .664), GABA levels in the ACC (p = .019), glutamate plus glutamine levels in the thalamus (p = .678), and the interaction term Ki4p × GABA (p = .016).ConclusionsOur multimodal approach proved superior classification accuracy, implying that the pathophysiology of patients represents a combination of neurotransmitter disturbances rather than aberrations in a single neurotransmitter. Particularly aberrant interrelations between Ki4p in the nucleus accumbens and GABA values in the ACC appeared to contribute diagnostic information.",
author = "Sigvard, {Anne K.} and Bojesen, {Kirsten Borup} and Ambrosen, {Karen S.} and Nielsen, {Mette {\O}degaard} and Albert Gjedde and Karen Tangmose and Yoshitaka Kumakura and Richard Edden and Dan Fugl{\o} and Jensen, {Lars Thorbj{\o}rn} and Egill Rostrup and Ebdrup, {Bj{\o}rn H.} and Glenth{\o}j, {Birte Yding}",
year = "2023",
doi = "10.1016/j.bpsgos.2022.05.004",
language = "English",
volume = "3",
journal = "Biological Psychiatry Global Open Science",
issn = "2667-1743",
publisher = "Elsevier",
number = "3",

}

RIS

TY - JOUR

T1 - Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model

AU - Sigvard, Anne K.

AU - Bojesen, Kirsten Borup

AU - Ambrosen, Karen S.

AU - Nielsen, Mette Ødegaard

AU - Gjedde, Albert

AU - Tangmose, Karen

AU - Kumakura, Yoshitaka

AU - Edden, Richard

AU - Fuglø, Dan

AU - Jensen, Lars Thorbjørn

AU - Rostrup, Egill

AU - Ebdrup, Bjørn H.

AU - Glenthøj, Birte Yding

PY - 2023

Y1 - 2023

N2 - BackgroundDisturbances in presynaptic dopamine activity and levels of GABA (gamma-aminobutyric acid) and glutamate plus glutamine collectively may have a role in the pathophysiology of psychosis, although separately they are poor diagnostic markers. We tested whether these neurotransmitters in combination improve the distinction of antipsychotic-naïve patients with first-episode psychosis from healthy control subjects.MethodsWe included 23 patients (mean age 22.3 years, 9 male) and 20 control subjects (mean age 22.4 years, 8 male). We determined dopamine metabolism in the nucleus accumbens and striatum from 18F-fluorodopa (18F-FDOPA) positron emission tomography. We measured GABA levels in the anterior cingulate cortex (ACC) and glutamate plus glutamine levels in the ACC and left thalamus with 3T proton magnetic resonance spectroscopy. We used binominal logistic regression for unimodal prediction when we modeled neurotransmitters individually and for multimodal prediction when we combined the 3 neurotransmitters. We selected the best combination based on Akaike information criterion.ResultsIndividual neurotransmitters failed to predict group. Three triple neurotransmitter combinations significantly predicted group after Benjamini-Hochberg correction. The best model (Akaike information criterion 48.5) carried 93.5% of the cumulative model weight. It reached a classification accuracy of 83.7% (p = .003) and included dopamine synthesis capacity (Ki4p) in the nucleus accumbens (p = .664), GABA levels in the ACC (p = .019), glutamate plus glutamine levels in the thalamus (p = .678), and the interaction term Ki4p × GABA (p = .016).ConclusionsOur multimodal approach proved superior classification accuracy, implying that the pathophysiology of patients represents a combination of neurotransmitter disturbances rather than aberrations in a single neurotransmitter. Particularly aberrant interrelations between Ki4p in the nucleus accumbens and GABA values in the ACC appeared to contribute diagnostic information.

AB - BackgroundDisturbances in presynaptic dopamine activity and levels of GABA (gamma-aminobutyric acid) and glutamate plus glutamine collectively may have a role in the pathophysiology of psychosis, although separately they are poor diagnostic markers. We tested whether these neurotransmitters in combination improve the distinction of antipsychotic-naïve patients with first-episode psychosis from healthy control subjects.MethodsWe included 23 patients (mean age 22.3 years, 9 male) and 20 control subjects (mean age 22.4 years, 8 male). We determined dopamine metabolism in the nucleus accumbens and striatum from 18F-fluorodopa (18F-FDOPA) positron emission tomography. We measured GABA levels in the anterior cingulate cortex (ACC) and glutamate plus glutamine levels in the ACC and left thalamus with 3T proton magnetic resonance spectroscopy. We used binominal logistic regression for unimodal prediction when we modeled neurotransmitters individually and for multimodal prediction when we combined the 3 neurotransmitters. We selected the best combination based on Akaike information criterion.ResultsIndividual neurotransmitters failed to predict group. Three triple neurotransmitter combinations significantly predicted group after Benjamini-Hochberg correction. The best model (Akaike information criterion 48.5) carried 93.5% of the cumulative model weight. It reached a classification accuracy of 83.7% (p = .003) and included dopamine synthesis capacity (Ki4p) in the nucleus accumbens (p = .664), GABA levels in the ACC (p = .019), glutamate plus glutamine levels in the thalamus (p = .678), and the interaction term Ki4p × GABA (p = .016).ConclusionsOur multimodal approach proved superior classification accuracy, implying that the pathophysiology of patients represents a combination of neurotransmitter disturbances rather than aberrations in a single neurotransmitter. Particularly aberrant interrelations between Ki4p in the nucleus accumbens and GABA values in the ACC appeared to contribute diagnostic information.

U2 - 10.1016/j.bpsgos.2022.05.004

DO - 10.1016/j.bpsgos.2022.05.004

M3 - Journal article

C2 - 37519478

VL - 3

JO - Biological Psychiatry Global Open Science

JF - Biological Psychiatry Global Open Science

SN - 2667-1743

IS - 3

ER -

ID: 346255836